Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 12374853)

1.

The discovery of susceptibility genes for mental disorders.

Cloninger CR.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13365-7. Epub 2002 Oct 8. Review. No abstract available.

2.

Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.

Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, Bougueleret L, Barry C, Tanaka H, La Rosa P, Puech A, Tahri N, Cohen-Akenine A, Delabrosse S, Lissarrague S, Picard FP, Maurice K, Essioux L, Millasseau P, Grel P, Debailleul V, Simon AM, Caterina D, Dufaure I, Malekzadeh K, Belova M, Luan JJ, Bouillot M, Sambucy JL, Primas G, Saumier M, Boubkiri N, Martin-Saumier S, Nasroune M, Peixoto H, Delaye A, Pinchot V, Bastucci M, Guillou S, Chevillon M, Sainz-Fuertes R, Meguenni S, Aurich-Costa J, Cherif D, Gimalac A, Van Duijn C, Gauvreau D, Ouellette G, Fortier I, Raelson J, Sherbatich T, Riazanskaia N, Rogaev E, Raeymaekers P, Aerssens J, Konings F, Luyten W, Macciardi F, Sham PC, Straub RE, Weinberger DR, Cohen N, Cohen D.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13675-80. Epub 2002 Oct 3. Erratum in: Proc Natl Acad Sci U S A 2002 Dec 24;99(26):17221. Ouelette, G [corrected to Ouellette, G]; Realson, J [corrected to Raelson, J].

3.

Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes.

Sacchetti E, Scassellati C, Minelli A, Valsecchi P, Bonvicini C, Pasqualetti P, Galluzzo A, Pioli R, Gennarelli M.

BMC Med Genet. 2013 Mar 9;14:33. doi: 10.1186/1471-2350-14-33.

4.

N-methyl-D-aspartate receptor hypofunction in schizophrenia could arise from reduced cortical connectivity rather than receptor dysfunction.

Hoffman RE, McGlashan TH.

Arch Gen Psychiatry. 1997 Jun;54(6):578-80. No abstract available.

PMID:
9193200
5.

The N-methyl-D-aspartate receptor and schizophrenia.

Strous RD, Javitt DC.

Isr J Med Sci. 1996 May;32(5):275-81. Review. No abstract available.

PMID:
8641863
6.

[Mutant mouse lacking D-amino-acid oxidase activity].

Konno R.

Seikagaku. 2008 Apr;80(4):337-43. Review. Japanese. No abstract available.

PMID:
18516913
7.

Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia.

Shinkai T, De Luca V, Hwang R, Müller DJ, Lanktree M, Zai G, Shaikh S, Wong G, Sicard T, Potapova N, Trakalo J, King N, Matsumoto C, Hori H, Wong AH, Ohmori O, Macciardi F, Nakamura J, Kennedy JL.

Neuromolecular Med. 2007;9(2):169-77.

PMID:
17627036
8.
9.

Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice.

Labrie V, Wang W, Barger SW, Baker GB, Roder JC.

Genes Brain Behav. 2010 Feb;9(1):11-25. doi: 10.1111/j.1601-183X.2009.00529.x. Epub 2009 Aug 5.

10.

D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia.

Corvin A, Donohoe G, McGhee K, Murphy K, Kenny N, Schwaiger S, Nangle JM, Morris D, Gill M.

Neurosci Lett. 2007 Oct 16;426(2):97-100. Epub 2007 Sep 8.

PMID:
17890006
11.

Disconnection and cognitive dysmetria in schizophrenia.

Friston K.

Am J Psychiatry. 2005 Mar;162(3):429-32. No abstract available.

PMID:
15741456
12.

Short-term and long-term effects of N-methyl-D-aspartate receptor hypofunction.

Greene R, Bergeron R, McCarley R, Coyle JT, Grunze H.

Arch Gen Psychiatry. 2000 Dec;57(12):1180-1; author reply 1182-3. No abstract available.

PMID:
11115333
13.

The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.

Verrall L, Burnet PW, Betts JF, Harrison PJ.

Mol Psychiatry. 2010 Feb;15(2):122-37. doi: 10.1038/mp.2009.99. Epub 2009 Sep 29. Review.

14.

Editorial: Etiological hypotheses of mental disorders at the molecular level.

Agam G, Ben-Shachar D.

Isr J Psychiatry Relat Sci. 2010;47(1):2-3. No abstract available.

15.

No association of G72 and D-amino acid oxidase genes with schizophrenia.

Liu YL, Fann CS, Liu CM, Chang CC, Wu JY, Hung SI, Liu SK, Hsieh MH, Hwang TJ, Chan HY, Chen JJ, Faraone SV, Tsuang MT, Chen WJ, Hwu HG.

Schizophr Res. 2006 Oct;87(1-3):15-20. Epub 2006 Jul 13.

PMID:
16842973
16.

D-amino acid oxidase activity is inhibited by an interaction with bassoon protein at the presynaptic active zone.

Popiolek M, Ross JF, Charych E, Chanda P, Gundelfinger ED, Moss SJ, Brandon NJ, Pausch MH.

J Biol Chem. 2011 Aug 19;286(33):28867-75. doi: 10.1074/jbc.M111.262063. Epub 2011 Jun 23.

17.

Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.

Williams M.

Biochem Pharmacol. 2009 Dec 1;78(11):1360-5. doi: 10.1016/j.bcp.2009.06.108. Epub 2009 Jul 8.

PMID:
19591808
18.

D-amino acid oxidase knockdown in the mouse cerebellum reduces NR2A mRNA.

Burnet PW, Anderson PN, Chen L, Nikiforova N, Harrison PJ, Wood MJ.

Mol Cell Neurosci. 2011 Jan;46(1):167-75. doi: 10.1016/j.mcn.2010.08.018. Epub 2010 Sep 7.

PMID:
20828614
19.

Neurodevelopmental hypothesis of schizophrenia: a central sensory disturbance.

Lafargue T, Brasic J.

Med Hypotheses. 2000 Oct;55(4):314-8.

PMID:
11000059
20.

Schizophrenia: signals from the other side.

Fischbach GD.

Nat Med. 2006 Jul;12(7):734-5. No abstract available.

PMID:
16829916
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk